POZEN POZN

  1. All
  2. Headlines
    1. Pernix acquires U.S. rights to Treximet

      Headlines

      Wed, 20 Aug 2014

      qtr). GSK assigned the product development and commercialization agreement (PDC Agreement) between GSK and Pozen (NASDAQ: POZN ) to Pernix. Updated 2014 guidance : revenue: $110M - 120M; non-GAAP EBITDA: $22M - 24M. 2015 guidance

    2. Pozen's ( POZN ) CEO John Plachetka on Q2 2014 Results - Earnings Call Transcript

      Headlines

      Thu, 7 Aug 2014

      Pozen , Inc. (NASDAQ: POZN ) Q2 2014 Earnings Conference Call August ..... Operator Greetings and welcome to the POZEN Incorporated second quarter 2014 ..... you, and good morning. On behalf of POZEN , I would like to welcome everyone to

    3. More on Pozen Q2 results

      Headlines

      Thu, 7 Aug 2014

      Pozen ( POZN +0.5% ) Q2 results : Revenues: $7.4M (+335.3%); Operating Expenses: $4.4M (-21.7%); Net Income: $3.0M (+175.2%); EPS: $0.09 (+169.2%); Quick Assets: $31.8M (-3.0%). No guidance given. Post your comment!

    4. Pozen ( POZN ) Q2 2014 Results - Earnings Call Webcast

      Headlines

      Thu, 7 Aug 2014

      The following audio is from a conference call that will begin on August 07, 2014 at 11:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now Complete Story »

    5. Great Buying Opportunity In Pozen Shares

      Headlines

      Wed, 30 Jul 2014

      By Jason Napodano : On July 28, 2014, Horizon Pharma, Inc. (NASDAQ: HZNP ) filed a Form 8-K with the SEC disclosing that two pharmacy benefit managers, CVS Caremark (NYSE: CVS ) and Express Scripts, Inc. (NASDAQ: ESRX ), expect to announce DUEXIS® and VIMOVO® will no longer be on their formularies

    6. Midday Gainers / Losers

      Headlines

      Mon, 28 Jul 2014

      12% . IMMY +9% . GLMD +9% . MOVE +8% . PCO +8% . Top 10 Losers: ACRX -41% . HZNP -34% . EDAP -27% . SMLR -20% . POZN -15% . LOAN -15% . CRNT -14% . VBFC -13% . PTX -11% . OTCQB:AMTX -10% . Post your comment!

    7. Pozen feels Horizon's pain

      Headlines

      Mon, 28 Jul 2014

      Shares of Pozen ( POZN -14.4% ) get smacked down on a 2x surge in volume in sympathy with Horizon Pharma's ( HZNP -33.2% ) bad news . Pozen earns a 10% royalty on Vimovo sales. Post your comment!

    8. Word Doctoring

      Headlines

      Fri, 21 Jun 2013

      resembling a consensus on best practices for money funds. For example, earlier this week two former fund executives, Robert Pozen and Terry Hamacher, penned an Opinion article in The Wall Street Journal that stated support for the first of the SEC's two

    Content Partners